Substance Use Disorder Headlines
Explore the latest public health research and insights about substance use disorder.
What to Know About Ketamine
Following a recent high-profile death, ketamine—for decades used as a popular party drug—came under public scrutiny for its use as a treatment for everything from psychiatric illnesses to autoimmune diseases.
Bloomberg School
Substance Use Disorder Faculty Experts
Looking for prominent public health experts in the field of substance use disorder? They’re here at the Bloomberg School of Public Health.
Professor
Epidemiology
G. Caleb Alexander, MD, MS, is a practicing internist and epidemiologist focused on maximizing the use, safety, and effectiveness of prescription medicines.
Professor
Health, Behavior and Society
Susan Sherman, PhD '00, MPH, brings harm reduction evidence to inform drug policy and programming in order to reduce overdose deaths and other harms to people who use drugs.
Associate Professor
Health, Behavior and Society
Sean Allen, DrPH, MPH, uses research to inform drug policies and eliminate health disparities among people who inject drugs.
Professor
Biostatistics
Elizabeth Stuart, PhD, uses statistical methods to help learn about the effects of public health programs and policies, often with a focus on mental health and substance use.
Associate Professor
International Health
Haneefa Tasleem Saleem, PhD ’14, MPH, ’09, conducts research to inform and evaluate approaches aimed at improving HIV prevention and treatment and other health outcomes for people who use drugs globally.
Associate Professor
International Health
Melissa Walls, PhD, MA, is an Indigenous researcher who works with American Indian and First Nations communities to promote health equity through culturally centered projects.